<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="26948,33283">Thiamine</z:chebi> supplementation may prevent and reverse early-stage diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This probably occurs by correcting <z:mp ids='MP_0002055'>diabetes</z:mp>-linked increased clearance of <z:chebi fb="4" ids="26948,33283">thiamine</z:chebi>, maintaining activity and expression of <z:chebi fb="0" ids="18290">thiamine pyrophosphate</z:chebi>-dependent enzymes that help counter the adverse effects of high <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations-particularly transketolase </plain></SENT>
<SENT sid="2" pm="."><plain>Evidence from experimental and clinical studies suggests that metabolism and clearance of <z:chebi fb="4" ids="26948,33283">thiamine</z:chebi> is disturbed in <z:mp ids='MP_0002055'>diabetes</z:mp> leading to tissue-specific <z:chebi fb="4" ids="26948,33283">thiamine</z:chebi> deficiency in the kidney and other sites of development of vascular complications </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="4" ids="26948,33283">Thiamine</z:chebi> supplementation prevented the development of early-stage <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in diabetic rats and reversed increased urinary albumin excretion in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> in two recent clinical trials </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="0" ids="9533">thiamine monophosphate</z:chebi> <z:chebi fb="0" ids="50266">prodrug</z:chebi>, Benfotiamine, whilst preventing early-stage development of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> experimentally, has failed to produce similar clinical effect </plain></SENT>
<SENT sid="5" pm="."><plain>The probable explanations for this are discussed </plain></SENT>
<SENT sid="6" pm="."><plain>Further definitive trials for prevention of progression of early-stage diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> by <z:chebi fb="4" ids="26948,33283">thiamine</z:chebi> are now required </plain></SENT>
</text></document>